Enliven Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2025 | 7.96 M | $162.93 M | 0.00% | 12.82% |
| FMR LLC | 11/13/2025 | 7.13 M | $145.93 M | -5.70% | 11.48% |
| COMMODORE CAPITAL LP | 11/14/2025 | 4.69 M | $96.06 M | 0.00% | 7.56% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 11/14/2025 | 3.71 M | $75.97 M | 0.00% | 5.98% |
| BLACKROCK, INC. | 11/12/2025 | 3.52 M | $72.02 M | 18.58% | 5.67% |
| VR ADVISER, LLC | 11/14/2025 | 3.23 M | $66.04 M | -19.87% | 5.20% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 3.10 M | $63.35 M | 1.47% | 4.98% |
| VANGUARD GROUP INC | 11/07/2025 | 2.55 M | $52.26 M | 5.91% | 4.11% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 1.79 M | $36.70 M | 4.50% | 2.89% |
| NOVO HOLDINGS A/S | 11/14/2025 | 1.43 M | $29.20 M | 31.52% | 2.30% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.40 M | $28.62 M | 44.50% | 2.25% |
| BLACKSTONE INC. | 11/14/2025 | 1.32 M | $27.03 M | 0.00% | 2.13% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2025 | 1.32 M | $26.93 M | 0.00% | 2.12% |
| CITADEL ADVISORS LLC | 11/14/2025 | 1.16 M | $23.76 M | -21.08% | 1.87% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 1.16 M | $23.75 M | 364.00% | 1.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.09 M | $22.21 M | 22.91% | 1.75% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 1.04 M | $21.30 M | -23.11% | 1.68% |
| STATE STREET CORP | 11/14/2025 | 965.14 K | $19.76 M | 18.24% | 1.55% |
| DUQUESNE FAMILY OFFICE LLC | 11/14/2025 | 947.41 K | $19.39 M | 104.62% | 1.53% |
| FIRST TURN MANAGEMENT, LLC | 11/14/2025 | 783.41 K | $16.04 M | 53.61% | 1.26% |
| 5AM VENTURE MANAGEMENT, LLC | 11/14/2025 | 772.48 K | $15.81 M | 0.00% | 1.24% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 686.11 K | $14.04 M | -2.18% | 1.11% |
| CANDRIAM S.C.A. | 11/06/2025 | 609.35 K | $12.47 M | 46.25% | 0.98% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 430.24 K | $8.81 M | 0.00% | 0.69% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 400.00 K | $8.19 M | 0.00% | 0.64% |
| NORTHERN TRUST CORP | 11/14/2025 | 394.45 K | $8.07 M | 21.51% | 0.64% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 381.41 K | $7.81 M | 19.77% | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 363.20 K | $7.43 M | 18.83% | 0.58% |
| MARSHALL WACE, LLP | 11/13/2025 | 340.48 K | $6.97 M | 2.14% | 0.55% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 340.00 K | $6.96 M | -2.86% | 0.55% |
| WOODLINE PARTNERS LP | 11/14/2025 | 300.50 K | $6.15 M | -72.70% | 0.48% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 262.27 K | $5.37 M | 38.40% | 0.42% |
| HIGHVISTA STRATEGIES LLC | 11/14/2025 | 259.14 K | $5.30 M | 83.11% | 0.42% |
| MORGAN STANLEY | 11/14/2025 | 258.38 K | $5.29 M | 1.39% | 0.42% |
| PATIENT SQUARE CAPITAL LP | 11/10/2025 | 250.84 K | $5.13 M | 2.03% | 0.40% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 231.30 K | $4.74 M | -56.21% | 0.37% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 200.00 K | $4.09 M | 0.00% | 0.32% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2025 | 166.77 K | $3.41 M | 29.76% | 0.27% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 160.46 K | $3.28 M | 242.49% | 0.26% |
| PFM HEALTH SCIENCES, LP | 11/14/2025 | 156.46 K | $3.20 M | 100.00% | 0.25% |
| AVIDITY PARTNERS MANAGEMENT LP | 11/14/2025 | 140.30 K | $2.87 M | 1,141.59% | 0.23% |
| AMERIPRISE FINANCIAL INC | 11/14/2025 | 123.34 K | $2.52 M | 108.18% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 115.62 K | $2.37 M | 17.82% | 0.19% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 114.83 K | $2.35 M | 0.00% | 0.18% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 108.56 K | $2.22 M | 15.47% | 0.17% |
| NUVEEN, LLC | 11/12/2025 | 108.24 K | $2.22 M | 20.66% | 0.17% |
| UBS GROUP AG | 11/13/2025 | 79.51 K | $1.63 M | -42.50% | 0.13% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 73.00 K | $1.49 M | -23.96% | 0.12% |
| BARCLAYS PLC | 11/12/2025 | 70.69 K | $1.45 M | -2.88% | 0.11% |
| SWISS NATIONAL BANK | 11/13/2025 | 63.17 K | $1.29 M | 2.10% | 0.10% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Enliven Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 149 institutional investors and hedge funds held shares of Enliven Therapeutics, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 7.96 M
FMR LLC: 7.13 M
COMMODORE CAPITAL LP: 4.69 M
Fairmount Funds Management LLC: 3.71 M
BlackRock, Inc.: 3.52 M
VR Adviser, LLC: 3.23 M
95.64% of Enliven Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 62.92 M shares in the last 24 months. This purchase volume represents approximately $1.23 B in transactions.